Guided by Science. Delivering for Patients.

We are focused on harnessing the power of the TGF-beta superfamily, the target-rich biology behind the body’s remarkable capacity for cellular growth and repair. Our insights and protein engineering capabilities enable us to design first- and best-in-class candidates for serious and rare pulmonary and hematologic diseases.

Read More

Acceleron

By the Numbers

Employees

0+

Employees and
Counting
Therapeutic Areas

0

Disease States
Proteins

0

Proteins in TGF-beta Superfamily
Clinical Trials

0

Clinical Trials
Regulatory Agencies

0

Regulatory Agencies
(U.S., E.U. & Canada)
have approved REBLOZYL®

Twitter Feed